BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 8607981)

  • 1. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms regulating Raf-1 activity in signal transduction pathways.
    Morrison DK
    Mol Reprod Dev; 1995 Dec; 42(4):507-14. PubMed ID: 8607983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
    Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
    Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.
    Kolch W; Philipp A; Mischak H; Dutil EM; Mullen TM; Feramisco JR; Meinkoth JL; Rose DW
    Oncogene; 1996 Sep; 13(6):1305-14. PubMed ID: 8808705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-related proteins in signal transduction and growth control.
    McCormick F
    Mol Reprod Dev; 1995 Dec; 42(4):500-6. PubMed ID: 8607982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Raf-1 serine/threonine protein kinase.
    Magnuson NS; Beck T; Vahidi H; Hahn H; Smola U; Rapp UR
    Semin Cancer Biol; 1994 Aug; 5(4):247-53. PubMed ID: 7803760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells.
    Traverse S; Cohen P; Paterson H; Marshall C; Rapp U; Grand RJ
    Oncogene; 1993 Nov; 8(11):3175-81. PubMed ID: 8414521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAF family: an expanding network of post-translational controls and protein-protein interactions.
    Yuryev A; Wennogle LP
    Cell Res; 1998 Jun; 8(2):81-98. PubMed ID: 9669024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras regulatory interactions: novel targets for anti-cancer intervention?
    Prendergast GC; Gibbs JB
    Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAF protein-serine/threonine kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.